Key result
Tat peptide-conjugated nuclease-resistant molecular beacons enabled nearly 100% intracellular delivery within 15 minutes and detection of as few as 1 infectious viral particle within 2 hours.
Tat-modified, nuclease-resistant molecular beacons enable rapid, real-time monitoring of viral replication and cell-to-cell spread in living cells.
May advance preclinical viral monitoring; leaves open clinical translation pending human validation.
In this study, we describe the use of nuclease-resistant molecular beacons (MBs) for the real-time detection of coxsackievirus B6 replication in living Buffalo green monkey kidney (BGMK) cells via Tat peptide delivery. A nuclease-resistant MB containing 2'-O-methyl RNA bases with phosphorothioate internucleotide linkages was designed to specifically target an 18-bp 5' noncoding region of the viral genome. For intracellular delivery, a cell-penetrating Tat peptide was conjugated to the MB by using a thiol-maleimide linkage. Presence of the Tat peptide enabled nearly 100% intracellular delivery within 15 min. When the conjugate was introduced into BGMK cell monolayers infected with coxsackievirus B6, a discernible fluorescence was observed at 30 min after infection, and as few as 1 infectious viral particle could be detected within 2 h. The stability and the intracellular delivery properties of the modified MBs enabled real-time monitoring of the cell-to-cell spreading of viral infection. These results suggest that the Tat-modified, nuclease-resistant MBs may be powerful tools for improving our understanding of the dynamic behavior of viral replication and for therapeutic studies of antiviral treatments.
No takes yet. Share an insight, caveat, or question.
Yeh et al. (2008) studied Coxsackievirus B6 infection (in vitro). Tat peptide-conjugated nuclease-resistant molecular beacons was evaluated on Real-time detection of viral replication. Tat peptide-conjugated nuclease-resistant molecular beacons enabled nearly 100% intracellular delivery within 15 minutes and detection of as few as 1 infectious viral particle within 2 hours.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: